High-throughput drug screening for targeting polyploid cancer cells with an interactive web portal
Open Access
- 2 February 2026
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 642, 218289
Abstract
No abstract availableKeywords
Funding Information
- University of Pittsburgh (S10OD028483)
- Medical Center, University of Pittsburgh
- Hillman Cancer Center, Medical Center, University of Pittsburgh
- National Institutes of Health (R21CA293424)
- National Institutes of Health (R00CA248944)
- National Institutes of Health (R03CA305794)
- National Institutes of Health (S10OD028483)
- National Institutes of Health (R03DE033361)
- National Institutes of Health (P50CA272218)
- National Institutes of Health (P30CA047904)
This publication has 16 references indexed in Scilit:
- High-Throughput Empirical and Virtual Screening To Discover Novel Inhibitors of Polyploid Giant Cancer Cells in Breast CancerAnalytical Chemistry, 2025
- Deep learning unlocks label-free viability assessment of cancer spheroids in microfluidicsLab on a Chip, 2024
- Single-cell morphological and transcriptome analysis unveil inhibitors of polyploid giant breast cancer cells in vitroCommunications Biology, 2023
- Whole-genome doubling confers unique genetic vulnerabilities on tumour cellsNature, 2021
- Discovering the anticancer potential of non-oncology drugs by systematic viability profilingNature Cancer, 2020
- Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistanceThe Prostate, 2019
- Defining a Cancer Dependency MapCell, 2017
- Docetaxel-induced polyploidization may underlie chemoresistance and disease relapseCancer Letters, 2015
- Generation of cancer stem-like cells through the formation of polyploid giant cancer cellsOncogene, 2013
- The advantages and disadvantages of being polyploidNature Reviews Genetics, 2005